XML 59 R50.htm IDEA: XBRL DOCUMENT v3.22.2
Segment Reporting - Revenues and Operating Income by Reportable Segment (Details)
$ in Millions
1 Months Ended 3 Months Ended 6 Months Ended
Mar. 31, 2022
USD ($)
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Jun. 30, 2022
USD ($)
segment
Jun. 30, 2021
USD ($)
Segment Reporting [Abstract]          
Number of operating segments | segment       2  
Segment Reporting Information [Line Items]          
Revenues   $ 615.4 $ 543.3 $ 1,211.6 $ 1,055.7
Adjusted EBITDA   86.1 75.9 163.2 148.8
Reconciliation of Adjusted EBITDA:          
Income before income taxes   19.6 6.1 63.7 17.1
Net income attributable to non-controlling interests   (33.7) (35.7) (64.3) (67.5)
Depreciation and amortization   28.0 25.2 55.4 50.9
Interest expense, net   56.9 53.4 113.2 106.7
Equity-based compensation expense   4.3 4.1 8.0 9.3
Transaction, integration and acquisition costs   8.2 11.4 15.3 20.8
Loss on disposals and deconsolidations, net   1.1 1.0 1.0 0.1
Loss (gain) on litigation settlement and other litigation costs   1.7 0.8 (29.1) 1.8
Loss on debt extinguishment   0.0 9.6 0.0 9.6
Adjusted EBITDA   86.1 75.9 163.2 148.8
Transaction and integration costs   8.2 9.2 15.3 14.5
Start-up costs     2.2   6.3
Other litigation costs   1.7 0.8 3.7 1.8
Litigation settlement $ (32.8) 0.0 0.0 (32.8) 0.0
Operating Segments | Surgical Facility Services          
Segment Reporting Information [Line Items]          
Revenues   597.9 525.8 1,176.7 1,021.6
Adjusted EBITDA   108.7 95.6 209.7 190.6
Reconciliation of Adjusted EBITDA:          
Adjusted EBITDA   108.7 95.6 209.7 190.6
Operating Segments | Ancillary Services          
Segment Reporting Information [Line Items]          
Revenues   17.5 17.5 34.9 34.1
Adjusted EBITDA   (0.8) (0.1) (0.7) (1.0)
Reconciliation of Adjusted EBITDA:          
Adjusted EBITDA   (0.8) (0.1) (0.7) (1.0)
All other          
Segment Reporting Information [Line Items]          
Adjusted EBITDA   (21.8) (19.6) (45.8) (40.8)
Reconciliation of Adjusted EBITDA:          
Adjusted EBITDA   $ (21.8) $ (19.6) $ (45.8) $ (40.8)